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Conradi: A New War on Drugs

COMMENT
A NEW WAR ON DRUGS: FIGHTING
STATE-SPONSORED OVERMEDICATION
OF CALIFORNIA’S FOSTER YOUTH
JESSIE CONRADI*
INTRODUCTION
DeAngelo was first removed from his mother when he was three
years old after she attempted suicide in front of him.1 After the removal,
he lived with his grandparents in San Francisco, where he grew up, but
still saw his mother during limited and supervised visits.2 At age eight, at
his mother’s direction, DeAngelo told his Child Protective Services
worker that his grandparents were abusing him so his mother could reassume custody.3 The guilt from this lie caused DeAngelo to act out in
school, and he was soon placed into a mental institution for an
evaluation.4
After this evaluation, DeAngelo was given Depakote and Klonopin
for sleep and Attention Deficit Hyperactivity Disorder (“ADHD”)—but
* Managing Editor, Golden Gate University Law Review, Volume 46; J.D. Highest Honors,
May 2016, Golden Gate University School of Law; M.S.W., The Catholic University, May 2011;
B.S.W., University of Utah, May 2008. I would like to thank Carol Barnett, my supervisor at East
Bay Children’s Law Offices who inspired me to write about this topic, and Michele Benedetto Neitz,
my faculty mentor.
1
Elaine Korry, California Moves to Stop Misuse of Psychiatric Meds in Foster Care, NPR
(Sept. 2, 2015), http://www.npr.org/sections/health-shots/2015/09/02/436350334/california-movesto-stop-misuse-of-psychiatric-meds-in-foster-care?utm_campaignstoryshare&utm_source=facebook.
com&utm_medium=social, archived at http://archive.is/ZpLUK.
2
Psychotropic Medication and Mental Health Services for Foster Youth: Seeking Solutions
for a Broken System: Hearing Before the S. Standing Comm. on Health & S. Standing Comm. on
Human Servs., 114th Cong., Sess. 1 (2015) [hereinafter Hearing] (statement of DeAngelo Cortijo),
http://www.digitaldemocracy.org/hearing/480?startTime=43&vid=SP1YjU0sIdc, archived at http://
archive.is/tdKmS.
3
Id.
4
Id.
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no other behavioral health services were provided.5 The drugs were
psychotropic substitutes for “the things any eight year-old needs to
sleep.”6
DeAngelo’s trauma at the hands of family members and the system
continued: he was sexually abused by a family friend; moved between
various group homes; not provided mental health treatment; and finally,
at age twelve, entered the juvenile justice system as he continued to act
out.7
Throughout these transitions, DeAngelo was prescribed several
drugs, including antipsychotics, antidepressants, and stimulants.8 He was
told that taking them was his only chance of being normal.9 Despite
years of treatment using psychotropic medication, DeAngelo experienced
the most profound improvement in his mental health after completing
equine therapy as a part of the Vision Quest program in Arizona.10 As he
was nearing his eighteenth birthday, he also participated in arts-based
programs where he performed poetry written about his mother,11 and
wrote plays using metaphors to process challenges that he had faced.12
DeAngelo is only one of thousands of children who are treated with
psychotropic medication – instead of much needed mental health services – in an attempt to resolve behavioral issues that often stem from
their difficult circumstances. His story is one of miscommunication between his providers and the system’s desire to treat the symptoms of
behavior instead of the underlying causes. While the suffering he encountered during his time in the foster care system was by no means
trivial, he was spared some of the harsher realities that affect other
overmedicated youth in the foster care system.
In June of 2008, six-year old Gabriel was brought into the Florida
Dependency System after experiencing neglect, trauma, and sexual
abuse.13 He was diagnosed with ADHD and Impulse Control Disorder
5

Id.
Id.
7
Id.
8
Korry, supra note 1.
9
Id.
10
Hearing, supra note 2.
11
Robert Gomez Hernandez, The Beat Within: “For You” by DeAngelo Cortijo, VIMEO (July
26, 2013), https://vimeo.com/65914769, archived at http://archive.is/UWoNC.
12
DeAngelo depicts himself as ice, and his mother as a meteor, “She seems dull to the fact
that she melts a part of me every time she comes around. I mean I love my mom but she’s slowly
killing me.” DeAngelo, The Heavens and Beyond, EACH ONE REACH ONE (2009), https://
sites.google.com/site/eachonereachoneeoro/eoro-youth/youth-plays/juvenile-justice-center/the-heavens-and-beyond-2009, archived at http://archive.is/Kc3Ck.
13
See Fla. Dep’t of Children & Families, Gabriel Meyers 4, 24, http://www.dcf.state.fl.us/
initiatives/GMWorkgroup/docs/GMPresentation.pdf (last visited Jan. 20, 2016)[hereinafter Gabriel].
6
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and prescribed multiple medications.14 His medication changed several
times during his year in foster care and he continued to act out through
tantrums and sexually inappropriate behavior.15 In June 2009, nine
months after entering the dependency system, Gabriel hanged himself in
the bathroom of his foster home after being sent to his room after a
tantrum.16
The U.S Food and Drug Administration (FDA) had not approved the
medications Gabriel was prescribed for use by children.17 The Florida
Department of Children and Family found that there was “insufficient
communication/coordination between the professionals involved with
Gabriel.”18 Also, the case manager had not obtained parental consent or a
court order for Gabriel’s psychotropic medication prescription as was
statutorily required.19
Gabriel’s story is an example of a tragic worst-case scenario, while
DeAngelo’s story is typical of what many foster children experience because of the tendency of caretakers in the foster system to try to medicate
problems as a “quick fix” for behavioral issues. Both children were unheard, minimally represented, and left without care by the very system
that was designed to protect them from abuse and neglect. In particular,
both cases demonstrate the perils of prescribing adult psychotropic medications to children absent the provision of mental health services.
The overmedication of foster care youth has been on the rise statistically and has also been drawing increased media attention.20 Tragic stories like Gabriel’s bring mismanagement of psychotropic medication to
the forefront. Additionally, class action lawsuits in Tennessee,21 Nevada,22 and Massachusetts23 have sought to hold the state accountable for
its neglect of foster youth. In February 2015, the San Francisco Chroni14

Id. at 16.
Id. at 26.
16
Id. at 56.
17
Michelle L. Mello, Note, Psychotropic Medication and Foster Care Children: A Prescription for State Oversight, 85 S. CAL. L. REV. 395, 396 (2012).
18
Gabriel, supra note 13, at 64.
19
Id. at 65.
20
Among other articles, Karen de Sá’s five part series, Drugging Our Kids, from the SAN
JOSE MERCURY NEWS (discussed infra) brought the plight of foster youth to the forefront in California. Her article was recognized with several journalistic awards, in large part because the article
exposed California’s dramatic overprescribing of foster youth. See Meiling Bedard, “Drugging Our
Kids” Wins Another Journalism Award, THE CHRONICLE OF SOCIAL CHANGE (June 30, 2015), https:/
/chronicleofsocialchange.org/news-2/drugging-our-kids-wins-another-journalism-award/10637.
21
Kimber E. Strawbridge, Article, The Children Are Crying: The Need for Change in Florida’s Management of Psychotropic Medication to Foster Children, 15 U.C. DAVIS J. JUV. L. &
POL’Y 247, 282-83 (2011).
22
Jessalyn Schwartz, Article, Overprescribed and Underserved: Psychotropic Medication
and Foster Care in the U.S., NW. UNIV. L. J. .: EXTRA LEGAL 6-7 (Fall 2013).
15
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cle published an editorial using strong language to highlight the need for
reform, calling it an “outrage that has been documented for many
years.”24
Further, in the 2015 legislative session, California was on the brink
of passing legislation to address these pressing issues. Senate Bill 253
(SB 253), described below, was one in a package of four bills designed
to provide oversight for the prescription of psychotropic medications.25
However, high priced lobbying on the part of California organizations
representing psychiatrists, doctors, and group homes prevented SB 253
from getting past the appropriations committee, and the bill died before
making it to the governor’s desk.26
California desperately needs to amend the law pertaining to the administration of psychotropic medication to foster youth. State policy affecting foster youth impacts many lives, as California is home to fifteen
percent of foster youth in the United States.27 While California began
offering such protections, a comprehensive amendment to California’s
law should address consent, case review for troublesome cases, monitoring, and a standard of review that matches the current standard used
when prescribing involuntary medication to adults. Anything less than
this falls short of the state’s duty to act, under the state’s parens patriae
power, as the foster youth’s parent.
This Comment will discuss the current problem with overmedication
of foster care youth, specifically in California. Part I outlines the immediate problems facing foster youth in the California dependency system
who have been prescribed psychotropic medication and examines the
federal and state laws that have attempted to address the issue. Part II
explains what federal law requires and several states’ interpretations,
specifically focusing on the definition of “oversight” and “monitoring.”
23
Martine Powers, Lawsuit Faults Mass. on Foster Care System, BOSTON GLOBE (Jan. 21,
2013), http://www.bostonglobe.com/metro/2013/01/21/class-action-case-against-mass-child-welfaresystem-start-trial-tuesday/yr6NaoTi6mIuCcNLfHXcyL/story.html.
24
Editorial, California Must Stop Overuse of Psychiatric Drugs for Foster Kids, S.F. CHRON.,
Feb. 2, 2015, http://www.sfchronicle.com/opinion/editorials/article/California-must-stop-overuse-ofpsychiatric-drugs-6057629.php.
25
Calif. Bills Targeting Foster Kids’ Medication Could Be National Model, CAL.
HEALTHLINE (Sept. 3, 2015), http://www.californiahealthline.org/articles/2015/9/3/calif-bills-targeting-foster-kids-medication-could-be-national-model#.VenqLlQDF_8.facebook.
26
Karen de Sá, California Assembly to Vote on Diminished Bill Package to Curb Psychotropic Drug Use on Foster Children, SAN JOSE MERCURY NEWS (Sept. 6, 2015, 4:54 PM), http://
www.mercurynews.com/california/ci_28769540/california-assembly-vote-diminished-bill-packagecurb-psychotropic.
27
Caroline Danielson & Helen Lee, Foster Care in California: Achievements and Challenges, PUB. POL’Y INST. OF CA 1, 8, http://www.ppic.org/content/pubs/report/R_510CDR.pdf (last
visited Nov. 13, 2015).

http://digitalcommons.law.ggu.edu/ggulrev/vol46/iss2/4

4

Conradi: A New War on Drugs

2016]

A New War On Drugs

91

Part III proposes an amendment to California’s law that addresses consent, case review, monitoring, and an adequate standard of review.
I. THE CURRENT STATE OF AFFAIRS IN CALIFORNIA
A. THE PROBLEM OF OVER PRESCRIBING
California’s foster care system includes about 60,000 children.28 In
California’s foster care system, almost one in four youth are prescribed
psychotropic medication – about 3.5 times the national rate.29 Therefore,
psychotropic medication policy affects a large number of foster youth
and is out of proportion with youth not in foster care.
The children in foster care are often especially vulnerable because of
previous abuse or neglect and the continued instability inherent in the
foster care system. More than sixty percent of youth that have been in
foster care longer than two years have moved at least twice,30 which
makes adhering to a schedule, attending regular doctor appointments,
and making other behavioral adjustments more difficult. The doctors
who are treating and prescribing medications for them often do not have
the children’s medical or drug history.31 Further, children in foster care
often stay on psychotropic medication longer than children out of care.32
Many children in foster care may also have a higher incidence of
experiencing trauma due to the circumstances that brought them into foster care; however, medications are often prescribed to change the youth’s
behavior without treating the underlying mental health deficiency.33 On
the other hand, some argue that the use of medications has contributed to
the deinstitutionalization of many foster care youth.34 Some children that
were previously required to stay in group homes or juvenile hall may be
able to return home or to another foster family with the assistance of
psychotropic medication.35 However, “therapy is often a secondary recommendation after prescribing a quick-fix medication to control” the
youth’s behavior.36
28
Karen de Sá, Drugging Our Kids, SAN JOSE MERCURY NEWS (Aug. 24, 2014), http://webspecial.mercurynews.com/druggedkids/?page=PT1.
29
Id.
30
Id.
31
Id.
32
William Grimm, Caring for our Kids: Are we Overmedicating Children in Foster Care?
PSYCHDRUGS ACTION CAMPAIGN (May 29, 2014), http://childpsychdrugsafety.org/caring-for-ourkids-are-we-overmedicating-children-in-foster-care/.
33
de Sá, supra note 27.
34
Id.
35
Id.
36
Strawbridge, supra note 20.
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1. Psychotropic Medication Defined
Psychotropic medication is defined by the California Rules of Court
as “those medications prescribed to affect the central nervous system to
treat psychiatric disorders or illnesses. They may include . . . antidepressants, mood stabilizers, antipsychotic medications . . . and psychostimulants.”37 These medications are typically used to treat mental health
conditions such as depression, anxiety, ADHD, bipolar disorder, psychosis, and obsessive-compulsive disorder.38
Psychotropic medications often have serious short- and long-term
side effects, including rapid-onset obesity, diabetes, and extreme lethargy.39 Some of the medications can impact brain development and can
even increase the risk of suicide.40 The FDA has approved only limited
uses and diagnoses for which psychotropic medications can be prescribed.41 There is no research on the effectiveness of these medications
on foster care youth.42
2. A Vulnerable Population
Twelve percent of youth in California’s foster care system who were
prescribed a psychotropic medication were prescribed two, three, or four
psychotropic medications at once.43 Combinations of medications increase the risk of known and unknown side effects, as there is little scientific evidence regarding such combinations.44 The concurrent use of
psychotropic medication can amplify each drug’s toxicity and side effects, including risk of death.45 The overlapping prescriptions often occur
when a child is prescribed psychotropic medication during a psychiatric
emergency and then retains the high-dosage prescription due to inadequate psychiatric follow-up.46 As the behavioral symptoms change, doctors often prescribe additional medications to modify behavior or to
adjust for side effects.47
37

CAL. R. CT. 5.640(a).
Mello, supra note 17, at 399??400.
39
de Sá, supra note 27.
40
Id.
41
Grimm, supra note 31.
42
Karen de Sá, Drugging Our Kids, Part IV: Finding Yolanda, SAN JOSE MERCURY NEWS
(Dec. 21, 2014), http://webspecial.mercurynews.com/druggedkids/?page=PT4.
43
de Sá, supra note 27.
44
PROTECTION & ADVOCACY, INC., PSYCHIATRIC POLYPHARMACY: A WORD OF CAUTION, 21
(June 2004), http://www.disabilityrightsca.org/pubs/702001.pdf.
45
Id. at 22.
46
de Sá, supra note 27.
47
Id.
38
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The overreliance on psychotropic medications is particularly acute
in group homes, where the most vulnerable and troubled foster care
youth are often placed. In California foster care group homes, almost half
of the youth are on psychotropic medication.48 This increased rate of
psychotropic medication in group homes may be attributed to lack of
staff training, a high youth-to-staff ratio, minimal useful therapeutic interventions, and a perception that “medications are effective in treating
behaviors and that non-pharmacological interventions may be less effective or too time-consuming to be part of standard care.”49 When youth in
group homes do not take their medications, they often face punishment
or removal of privileges.50
Youth in the foster care system are particularly vulnerable to being
inappropriately medicated using psychotropic drugs. Because youth in
foster care have a higher incidence of experiencing trauma, they are also
at a higher risk of “ ‘mental health problems, difficulties with social relationships and behavior, physical illness, and poor school performance.’
Unfortunately, such traumatic stress symptoms are often identical to the
symptoms that indicate other mental health conditions, which may lead
to misdiagnosis and inappropriate treatments.”51 In foster or group
homes, psychotropic medications are used more frequently due to their
effect in decreasing some of the child’s troublesome behaviors.52 Even
though a child’s problematic behavior might be symptoms of a rebellious
phase or normal childhood development,53 “it’s just cheaper and easier to
drug kids than to take care of them in the most therapeutically appropriate way.”54 Instead of the foster care system employing resources to ascertain or address these children’s problems with age-appropriate
techniques, the children are drugged. The current guidelines regarding
use of psychotropic medications in children are inadequate to protect
these children from overmedication, even when well-intentioned. Something greater is needed to promote a paradigm shift away from depen48

de Sá, supra note 27.
Grimm, supra note 31.
50
de Sá, supra note 27.
51
Donald H. Stone, The Dangers of Psychotropic Medication for Mentally Ill Children:
Where is the Child’s Voice in Consenting to Medication? An Empirical Study, 23 TEMP. POL. & CIV.
RTS. L. REV. 121, 144 (2013) (citing U.S. Gov’t Accountability Office, GAO-13-15, Children’s
Mental Health: Concerns Remain About Appropriate Services for Children in Medicaid and Foster
Care 1 (2012)).
52
Id. at 140.
53
Maggie Brandow, Note, A Spoonful of Sugar Won’t Help This Medicine Go Down: Psychotropic Drugs for Abused and Neglected Children, 72 S. CAL. L. REV. 1151, 1160 (1999).
54
Jonathan Walters, Are We Overmedicating Foster Care Children?, GOVERNING MAG. (Oct.
8, 2013), http://www.governing.com/topics/health-human-services/col-overmedicating-foster-carechildren-human-services.html.
49
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dence on medications. This shift should be facilitated through a change
in state or federal law.
B. CURRENT LAW ON PSYCHOTROPIC MEDICATION
1. Federal Law
Two federal laws govern the use of psychotropic medications for
children. They provide general guidelines that set a framework for states
to adopt their own statutes. Congress addressed the growing need for
support of foster youth in two different acts: The Fostering Connections
to Success and Increasing Adoptions Act of 2008 (“FCS”) and the Child
and Family Services Improvement and Innovation Act of 2011 (“CFS”).
The Fostering Connections to Success and Increasing Adoptions Act
of 2008 amended the Social Security Act to include the first federal statutory reference to the mental health of foster care children.55 The FCS
urges the states to develop a coordinated plan for the ongoing oversight
of the mental health needs of the foster care child.56 This oversight is to
include consultation with a pediatrician as well as experts in health care
and child welfare.57 This section also specifically states that oversight
shall be provided for prescription medication.58 However, “oversight” is
not defined and is therefore left to the states to interpret.
The Child and Family Services Improvement and Innovation Act
(2011) also amended the Social Security Act. It adds language to the
Social Security Act that requires protocols for the “appropriate use and
monitoring of psychotropic medications” administered to foster care
youth.59 It also calls for mental health care that is “child-specific, comprehensive, appropriate, and consistent.”60 However, this “monitoring”
was not further elaborated upon by CFS, leaving it in the hands of the
states to determine how to apply it.
Federal law only provides general guidance, on the premise that
each state has different factors that will affect the foster care system
within the state, and which will require guidelines that are specifically
tailored to those factors. State laws governing medication for youth in
55

Fostering Connections to Success and Increasing Adoptions Act of 2008, Pub. L. No. 110351, 122 Stat. 3949 (codified as amended in scattered sections of 42 U.S.C.); 42 U.S.C.A § 1305
Note (West 2011).
56
42 U.S.C.A § 622(b)(15)(A).
57
Id.
58
42 U.S.C.A. § (b)(15)(A)(v).
59
Child and Family Services Improvement and Innovation Act of 2011, Pub. L. No. 112-34,
125 Stat. 369 (codified as amended in scattered sections of 42 U.S.C.); 42 U.S.C.A § 1320a9(a)(7)(B) (West 2011).
60
42 U.S.C.A § 1320a-9(a)(7)(B).
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foster care may differ depending on characteristics, such as whether the
state is urban or rural, whether child-welfare services are delivered
through the county or the state, and whether practitioners are available.61
Despite state differences, the Administration for Children and Families, a
federal agency, suggested that state policies should include provisions for
treatment screening, informed consent, information sharing, medication
monitoring at the patient and agency level, and availability of mental
health consultation by a Board Certified Child Psychiatrist.62
2. California Law
In California, the requirement for oversight is addressed in the rules
for the Dependency System, contained in the Welfare and Institutions
Code. Unless otherwise specified, the court is held to a preponderance of
the evidence standard for all findings, including those pertaining to the
administration of medication.63 Preponderance of the evidence is typically a civil standard, meaning the existence of a fact is more probable
than its nonexistence,64 or more than fifty percent probable.
When the state removes a child from parental custody, the child is
appointed an attorney.65 The attorney is “charged in general with the
representation of the child’s interest.”66 However, there are no specific
provisions requiring the attorney to represent the youth’s mental health
interests or calling for the attorney to contact the youth’s doctor or
psychiatrist.67
For youth in California’s foster system, only a juvenile court judicial
officer (most commonly a judge) can authorize the administration of
psychotropic medications, but the process to secure that authorization has
dire gaps and weaknesses. The law states that “only a juvenile court judicial officer shall have authority to make orders regarding the administration of psychotropic medications. . . .”68 The court makes its decision
based on the physician’s request, the basis for that request, the child’s
diagnosis and behavior, and the effects of the medication, both those intended and the side effects.69 To provide the court with this information,
61
ADMIN. ON CHILDREN, YOUTH AND FAMILIES, U.S. DEP’T OF HEALTH AND HUMAN SERVS.:
INFORMATION MEMORANDUM ACYF-CB-IM-12-03, 13 (2012), https://www.acf.hhs.gov/sites/default/files/cb/im1203.pdf.
62
Id.
63
CAL. EVID. CODE § 115 (West 2016).
64
Lillian F. v. Sup. Ct., 160 Cal. App. 3d, 314, 320 (Ct. App. 1984).
65
CAL. WELF. & INST. CODE § 317(c) (West 2016).
66
Id. § 317(e)(1).
67
Id. § 317.
68
Id. § 369.5(a).
69
Id.
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the Judicial Council has adopted forms and rules of court for implementation.70 The only exception to this procedure is for emergency administration of medication, which is covered in a different statute.71
In 2007, the California Judicial Council established the forms for
oversight of psychotropic medication for youth in foster care:72
• JV-219: Information About Psychotropic Medication Forms,
• JV-220: Application Regarding Psychotropic Medication,
• JV-220(A): Prescribing Physician’s Statement,
• JV-221: Proof of Notice: Application Regarding Psychotropic
Medication,
• JV-222: Opposition to Application Regarding Psychotropic Medication, and
• JV-223: Order Regarding Application for Psychotropic
Medication.
To fulfill notice requirements, the JV-220, JV-220(A), and JV-222
forms must be provided to the parents, caregiver, Court Appointed Special Advocate (CASA), Indian Tribe (if applicable), and all parties’
attorneys.73
Any time a foster youth needs a new psychotropic medication prescription, or every six months for foster youth already on psychotropic
medication, the JV-220 must be filled out by the prescribing physician
and the youth’s social worker and then submitted to the court for review.74 The JV-220 and JV-220(A) forms are mandatory and require the
information specified by California Welfare & Institutions Code Section
369.5.75 The three-page JV-220(A) form requests the physician write the
youth’s diagnosis and symptoms, the last face-to-face contact with the
youth, other individuals from whom information about the youth was
obtained, treatment that the youth is receiving besides medication, and
the list of medications and their potential side effects.76 This form allows
for multiple medications to be listed, as well as “as needed”
medications.77
70

Id.
CAL. R. CT. 5.640(g).
72
NAT’L CONF. OF STATE LEG., NCSL CHILD WELFARE LEGISLATION UPDATE, OVERSIGHT
AND MANAGEMENT OF PSYCHOTROPIC MEDICATIONS FOR CHILDREN AND YOUTH IN FOSTER CARE
(2013).
73
CAL. R. CT. 5.640(g).
74
JUDICIAL COUNCIL OF CALIFORNIA, APPLICATION REGARDING PSYCHOTROPIC MEDICATION
(2008), http://www.courts.ca.gov/documents/jv220.pdf.
75
CAL. R. CT. 5.640(c)(1).
76
CAL. R. CT. 5.640(c)(6)(A)(G).
77
JUDICIAL COUNCIL OF CALIFORNIA, APPLICATION REGARDING PSYCHOTROPIC MEDICATION
(2008), http://www.courts.ca.gov/documents/jv220.pdf.
71
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If anyone opposes the administration of medication for any reason,
they can submit the JV-222 form to the court and parties required to
receive notice.78 This form requests basic information about the individual opposing the application and a statement stating why the application
is opposed.79 It must be submitted within four court days after the JV220 service of notice.80 The court must then conduct a hearing prior to
completing the order.81
Neither the form nor the California code has any restrictions on the
number, doses, or combination of psychotropic medication that the youth
can be prescribed and required to take.82 The prescribing physician is not
required to see the youth with any regularity or ever again.83 The youth
need not be enrolled in any other type of treatment.84 The prescribing
physician is not required to consult with anyone else in the youth’s support network.85 The only check on the JV-220 process is the ability for a
party to oppose the request through a JV-222 or the denial or modification of the request by the court. The use of this court oversight has not
led to a decrease in the administration of psychotropic medication to foster youth.86
If there is no opposition, the judge considers all of the submitted
forms and then makes an order, JV-223, granting the request, granting
the request with modifications, or denying the request.87 This is the entirety of the oversight process for a youth to be prescribed and receive
psychotropic medications.
While a minor twelve years of age or older can refuse medication,
most youth will not refuse medication because they trust the doctors that
are prescribing for them. Other youth may not refuse medication for fear
of punishment from caregivers.88 As the court is taking on the role of the
78

CAL. R. CT. 5.640(c)(8).
JUDICIAL COUNCIL OF CALIFORNIA, OPPOSITION TO APPLICATION REGARDING PSYCHOTROPIC MEDICATION (2014), http://www.courts.ca.gov/documents/jv222.pdf.
80
CAL. R. CT. 5.640(c)(8).
81
CAL. WELF. & INST. CODE § 317(c).
82
Whitney Richey Rubenstein, Raising Red Flags: A Look at State Policies for Prescribing
Psychotropic Meds for Foster Children, NAT’L CTR. FOR YOUTH L., https://web.archive.org/web/
20151108064448/http://youthlaw.org/publication/raising-red-flags-a-look-at-state-policies-for-prescribing-psychotropic-meds-for-foster-children/.
83
An examination of the California Rules of court reveals no additional requirements beyond
those included in the rule. See CAL. R. CT. 5.640.
84
Id.
85
CAL. R. CT. 5.640.
86
Karen de Sá, Drugging Our Kids, SAN JOSE MERCURY NEWS (Aug. 24, 2014), http://webspecial.mercurynews.com/druggedkids/?page=PT1.
87
CAL. R. CT. 5.640(d); JUDICIAL COUNCIL OF CALIFORNIA, ORDER REGARDING APPLICATION
FOR PSYCHOTROPIC MEDICATION (2008), http://www.courts.ca.gov/documents/jv223.pdf.
88
de Sá, supra note 85.
79
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child’s parent, it is also responsible to consent on the child’s behalf and
should conduct a thorough investigation into the medication as would a
concerned parent. Other states have enacted legislation to facilitate this
investigation.
3. Other State Regimes
The American Academy of Children and Adult Psychiatry (AACAP) developed a three-part guideline to evaluate the existing laws regarding the prescription and administration of psychotropic medication
to youth in foster care.89 First, many states have established the use of
“red flags” in psychotropic treatment.90 Red flags are circumstances that
automatically trigger review or heightened scrutiny.91 Generally, red
flags include the age of the minor, the dosage of the medication, or the
combination of medications.92 Second, several states address informed
consent in their legislation through procedures that permit the child’s
caregiver, parent, social services agency, or the court to consent to
psychotropic medication.93 Third, some states require ongoing monitoring of the youth and their treatment as it relates to the psychotropic medication, including medical screenings and regular psychiatry
appointments.94 Not addressed in AACAP’s guidelines, but vital to a
law’s success, is the standard of review by which the court will be reviewing the evidence.
4. Standard of Evidence for Adults Receiving Involuntary
Medications
Children are not afforded the same protections as adults when it
comes to their ability to avoid psychotropic medication in an institutional
setting. For adults in the penal or civil commitment system, the freedom
from bodily intrusion through psychotropic medication is protected by
California’s Constitutional right to privacy.95 The Lanterman-PetrisShort Act (LPS) went into effect in 1972 as a further protection of this
right.96 LPS was passed to better protect the rights of civilly committed
89

Rubenstein, supra note 81.
Id.
91
Id.
92
Id.
93
Id.
94
Id.
95
In re Qawi, 81 P.3d 224 (Cal. 2004) (quoting Conservatorship of Wendland, 28 P.3d 151,
15860 (2001)).
96
CAL. WELF. & INST. CODE § 5000.
90
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persons.97 Under this Act, a civilly committed individual has the right to
refuse psychotropic medication unless one of the following conditions is
met: (1) the person is determined to be incompetent regarding decisions
involving their treatment; (2) the medication is required in an emergency
situation; or (3) the person was committed under section 5300 and there
is a particularized showing that the patient is a demonstrated danger and
has recently been dangerous.98 LPS has been a model for mental health
and medication regulations in other areas of law.
In 1986, the California Court of Appeal for the First District reiterated the importance of protecting incarcerated adults from bodily invasion of privacy through forced medication.99 In Keyhea, a prisoner
brought a taxpayer suit against the state after being forcibly medicated
without a judicial determination of competency.100 The Court of Appeal
recognized the prisoner’s right to privacy as derived from a non-prisoner’s right as protected under the LPS.101 Under LPS, conservatees
have a right to a judicial determination of competency prior to being
forcibly medicated with psychotropic medications against their will.102
The court concluded that the prisoner was entitled to the same rights
regarding judicial determination of their competency to refuse medication that are afforded to non-prisoners under LPS.103 The court noted,
“mental health professionals and prison administrators may find this requirement cumbersome, but this is a price of life in a free society. Forced
drugging is one of the earmarks of the gulag. It should be permitted in
state institutions only after adherence to stringent substantive and procedural safeguards.”104
After Keyhea, California enacted Penal Code Section 2602, which
adds protections for adults in the prison system, including a clear and
convincing standard of evidence required for involuntary administration
of medication.105 Section 2602 requires that a prisoner who does not consent to receiving psychotropic medication can only be medicated if cer97
CAL. WELF. & INST. CODE § 5001 (“construed to support. . .[an] end the inappropriate,
indefinite, and involuntary commitment of persons with mental health disorders, developmental disabilities, and chronic alcoholism, and to eliminate legal disabilities.”)
98
Qawi, 81 P.3d at 23436.
99
See Keyhea v. Rushen, 178 Cal. App. 3d 526 (Ct. App. 1986) (“state prisoners presently
have a statutory right to refuse long-term treatment with psychotropic drugs absent a judicial determination that they are incompetent to do so.”).
100
Id.
101
See id. at 534.
102
Keyhea, 178 Cal. App. 3d at 536; CAL. WELF. & INST. CODE §§ 5325, 5327.
103
Keyhea, 178 Cal. App. 3d at 542; CAL. WELF. & INST. CODE §§ 5325, 5327.
104
Keyhea, 178 Cal. App. 3d at 542.
105
CAL. PENAL CODE § 2602 (West 2016).
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tain conditions are met.106 These conditions include: (1) prisoner has a
demonstrably and factually-based diagnosed mental disorder that renders
him gravely disabled;107 (2) the psychiatrist has evaluated the risks and
benefits of medicating the prisoner after consulting the prisoner’s medical and psychiatric history;108 (3) the prisoner is entitled to counsel and a
hearing;109 and (4) the judge makes a finding based on “clear and convincing” evidence that the above listed are true.110
Children in the foster care system, while not civilly committed or
incarcerated, have limited rights due to their status as children and wards
of the state. Unlike prisoners or committed adults, children do not even
have the legal right to consent to psychotropic medication; they may only
assent.111
However, like prisoners and civilly committed adults, children are
entitled to most of the due process protections of the Fourteenth Amendment. “It is not disputed that the child, in common with adults, has a
substantial liberty interest in not being confined unnecessarily for medical treatment and that the state’s involvement in the commitment decision constitutes state action under the Fourteenth Amendment.”112
Similarly, the state approving medication for a child who is in foster care
constitutes state action and implicates serious protected liberty interests
for the child.
C. PREVIOUS LEGISLATIVE EFFORTS: SENATE BILL 253
The California legislature has seen recent activity designed to address the gaps in the current legal framework governing the provision of
psychotropic medication to foster youth. In the 2015 legislative session,
Senator Monning (D-Carmel) introduced Senate Bill 253 (SB 253) as
part of a package of four bills meant to curb the overmedication of foster
youth.113 Since presently a juvenile officer is required to approve the JV220, SB 253 was aimed at modifying the required bases for a court’s
106

Id.
Id. § 2602 (c)(1)-(2), (c)(7)(A).
108
Id. § 2602 (c)(4).
109
Id. § 2602(c)(6)-(7).
110
Id. § 2602(c)(8).
111
AM. ACAD. OF CHILD & ADOLESCENT PSYCHIATRY, A GUIDE FOR COMMUNITY CHILD
SERVING AGENCIES ON PSYCHOTROPIC MEDICATIONS FOR CHILDREN AND ADOLESCENTS, 9 (2012),
http://www.aacap.org/app_themes/aacap/docs/press/guide_for_community_child_serving_agencies_
on_psychotropic_medications_for_children_and_adolescents_2012.pdf.
112
Parham v. J.R., 442 U.S. 584, 600 (1979).
113
Calif. Bills Targeting Foster Kids’ Medication Could Be National Model, CAL.
HEALTHLINE (Sept. 3, 2015), http://www.californiahealthline.org/articles/2015/9/3/calif-bills-targeting-foster-kids-medication-could-be-national-model#.VenqLlQDF_8.facebook.
107
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findings prior to the prescription of psychotropic medication.114 SB 253
would have required that the doctor, prior to prescribing the medication,
meet with the foster youth, complete a comprehensive medical examination that included the child’s trauma and medication history, and speak to
other medical providers working with the youth.115 Further, the doctor
would be required to confirm that there are no less invasive treatment
options, that the medicine and dosage are appropriate, that all appropriate
labs and testing are completed, and that the risks do not outweigh the
benefits.116
The court also would have been required to request a second medical
opinion from “an appropriately qualified health care professional” if any
of the following conditions exist: (1) the child is under the age of five;
(2) the child is receiving more than three psychotropic medications; or
(3) the child is concurrently prescribed two or more antipsychotic
medications.117
Most of the language in the proposed amendment to the statute
comes from the practice parameters and recommendations outlined by
AACAP. The Practice Guide on the Use of Psychotropic Medication in
Children and Adolescents states, “[b]ecause a medication intervention in
a child is a significant medical event, it is prudent to complete a medical
evaluation to ensure that the child has no medical problem accounting
for the psychiatric presentation and is healthy enough to participate in a
medication trial with minimal risk.”118 Further, the prescriber is advised
to “communicate with other professionals involved with the child to obtain collateral history.”119
In the Practice Parameter for the Assessment and Management of
Youth Involved with the Child Welfare System, prescribing physicians
are informed that they “should recognize that maltreatment and trauma
can be complex and chronic, leading to a confusing clinical presentation
that might be difficult to differentiate from other mental health
conditions.”120
114

Juveniles: Psychotropic Medication, S.B. 253, 2015-2016 Sess. (Cal. 2015), http://
leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=201520160SB253#content_anchor.
115
Id.
116
Id.
117
Id.
118
John Walkup et al., Practice Parameter on the Use of Psychotropic Medication in Children and Adolescents, 48 J. AM. ACAD. CHILD & ADOLESCENT PSYCHIATRY 961, 964 (2009) (emphasis added), http://www.jaacap.com/article/S0890-8567(09)60156-8/pdf.
119
Id.
120
Terry Lee et al., Practice Parameter for the Assessment and Management of Youth Involved with the Child Welfare System, 54 J. AM. ACAD. ADOLESCENT & CHILD PSYCHIATRY 502,
511 (2015), http://www.jaacap.com/article/S0890-8567(15)00148-3/pdf.

Published by GGU Law Digital Commons, 2016

15

Golden Gate University Law Review, Vol. 46, Iss. 2 [2016], Art. 4

102

GOLDEN GATE UNIVERSITY LAW REVIEW

[Vol. 46

However, the California Medical Association, the California Psychiatric Association, the California Academy of Adolescent and Child Psychiatry, and the California Alliance of Child and Family Services,
representing group homes, all opposed the bill and called for a “no” vote
even after SB 253 had unanimously passed the senate.121 Combined,
these groups spent more than $1.4 million dollars lobbying against the
bill between January 1 and June 1, 2015.122 Those opposed to the bill
stated that SB 253 would have had the unintended consequence of harming foster youth through restricting their access to medically appropriate
medications.123 However, SB 253 would not have prevented any medications from being prescribed – it only would have provided additional
oversight.
While the three other bills in the package do address some of the
issues that give rise to overmedication, SB 253 was the “linchpin” of the
package, because “the courts are the gatekeepers.”124 The other bills require the state to provide more practitioner training and data on the number of youth that are on psychotropic medication,125 establish a system
for public health nurses to oversee youth in foster care that are prescribed
psychotropic medication,126 and provide additional oversight to foster
youth on psychotropic medication who are residing in group homes.127
Without oversight by the courts through an amendment to California
Welfare & Institutions Code Section 369.5, the efforts through public
health nurses and group homes will not provide the needed substantive
change.

121
Karen de Sá, California Assembly to Vote on Diminished Bill Package to Curb Psychotropic Drug Use on Foster Children, SAN JOSE MERCURY NEWS (Sept. 6, 2015, 4:54 PM), http://
www.mercurynews.com/california/ci_28769540/california-assembly-vote-diminished-bill-packagecurb-psychotropic.
122
Id.
123
Randall Hagar, Letter to the Editor, Better Mental Health Plan for Foster Kids, OROVILLE
MERCURY REG.: SEPT. 10 READERS’ LETTERS (Sept. 10, 2015), http://www.orovillemr.com/generalnews/20150909/sept-10-readers-letters.
124
de Sá, Diminished Bill Package, supra note 120.
125
Foster Care: Psychotropic Medication, S.B. 238, 205 (Cal. 2015), https://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=201520160SB238.
126
Child-Welfare Services: Public Health Nursing, S.B. 319, 2015. (Cal. 2015), http://
leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=201520160SB319.
127
Juveniles, S.B. 484, 2015. (Cal. 2015), http://leginfo.legislature.ca.gov/faces/
billNavClient.xhtml?bill_id=201520160SB484.
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II. OVERSIGHT & MONITORING
A. A STATE COMPARISON
Since the federal statutes do not define oversight and monitoring,
other state statutes provide the best examples of the various ways to implement a framework that accomplishes the federal goals. Currently,
twenty-six states have a written policy or guideline regarding the administration of psychotropic medication to foster youth, thirteen states are in
the process of developing policy, and only nine states have no policy in
place.128
Three of the states that have established the most comprehensive
oversight and monitoring of psychotropic medications are Illinois, Texas,
and Nevada. Both Illinois and Texas have procedures in their legislation
that require case review in the presence of enumerated red flags. Nevada’s law requires assignment of psychiatric rights of the child.129
1. Texas Law
In Texas, House Bill (HB 915) “ensures that the use of psychotropic
medications by foster youth is appropriate, necessary, and monitored.”130
The bill addresses consent, requiring consent by the youth or the individual authorized to consent on behalf of the youth.131 Additionally the
youth or an authorized individual receives:
. . . verbally or in writing information that describes the specific condition to be treated, the beneficial effects on that condition expected
from the medication, the probable health and mental health consequences of not consenting to the medication, the probable clinically
significant side effects and risks associated with the medication, and
the generally accepted alternative medications and non-pharmacological interventions to the medication, if any, and the reasons the physician recommends the proposed course of treatment.132
128

Tufts CTSI, Multi-State Study on Psychotropic Medication Oversight in Foster Care,
(Sept. 2010).
129
Whitney Richey Rubenstein, Raising Red Flags: A Look at State Policies for Prescribing
Psychotropic Meds for Foster Children, NAT’L CTR. FOR YOUTH L., https://web.archive.org/web/
20151108064448/http://youthlaw.org/publication/raising-red-flags-a-look-at-state-policies-for-prescribing-psychotropic-meds-for-foster-children/.
130
B. Analysis for H.B. 915, S. Research Center-83R14889 MCK-F. (Tex. 2013), http://
www.legis.state.tx.us/tlodocs/83R/analysis/html/HB00915E.HTM.
131
TEX. FAM. CODE ANN. § 266.004 (West 2015).
132
Id. § 266.0042(2).
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This signed authorization must stay in the youth’s file and with their
medical records.133 The individual who is authorized to consent must
also receive training on consent and relevant medical care134 and accompany the minor to medical appointments.135
To satisfy the federal requirement for monitoring, Texas requires
that the individual who is authorized to consent for the child ensures that
the child has an office visit with the prescribing physician at least every
ninety days.136 During these visits, the physician should be monitoring
the side effects of the current medications, evaluating whether the medication is helping the child progress toward his treatment goals, as well as
determining whether the continued use of the medication is necessary.137
Follow-ups also provide an opportunity for the physician to reevaluate
high-dosage prescriptions that may have been implemented for a psychiatric emergency. Further monitoring occurs during each review and permanency hearing. The state provides summaries for each youth on
psychotropic medication that contains information about their medical
treatment, including non-pharmacological interventions that have been
utilized, and recent office visits with the treating physician.138
Texas’ statute, by defining and assigning consent, adds a safeguard
on the prescription of psychotropic medication. For each child that is
prescribed psychotropic medication, a trained individual must be educated about the medication and sign off on its administration. Additionally, the office visit requirement serves as scaffolding to ensure the
medication is still a working part of the youth’s treatment goals. The
prescribing physician has an opportunity to place eyes on the child and
the child can communicate directly about the impact and side effects of
the medication.
2. Nevada Law
In 2011, Nevada passed a law that requires court appointment of a
person legally responsible for the psychiatric care of the foster care
youth.139 This individual’s responsibilities include maintaining up-todate information on the youth’s medical history as well as providing
133

B. Analysis for H.B. 915, S. Research Center-83R14889 MCK-F. (Tex. 2013), http://
www.legis.state.tx.us/tlodocs/83R/analysis/html/HB00915E.HTM.
134
FAM. CODE ANN. §§ 266.004(h).
135
Id. § 266.004(j).
136
Id. § 263.306(a)(10)(B).
137
Id. § 263.306(a)(11).
138
Id. § 263.306(a)(10)(A).
139
NAT’L CONF. OF STATE LEG., NCSL CHILD WELFARE LEGISLATION UPDATE, OVERSIGHT
AND MANAGEMENT OF PSYCHOTROPIC MEDICATIONS FOR CHILDREN AND YOUTH IN FOSTER CARE
(2013).
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written consent to the administration of psychotropic medications.140 By
statute, that person must consider the “purpose, benefits, risks, alternatives, side effects, and complications of each psychotropic
medication.”141
Similar to the Texas law, the Nevada law’s psychiatric rights holder
provides intentional and educated support and consent regarding psychiatric care. In all cases, but especially for those where children may be too
young or underdeveloped to consent to medication, the court’s appointment of a psychiatric rights holder empowers a normally vulnerable
population.
3. Illinois Law
The Illinois law pertaining to psychotropic medications for foster
youth is one of the most comprehensive in the nation. It requires publication of the guidelines for utilization psychotropic medication on the Illinois Department of Children and Family Services’ website.142 The law
explicitly prohibits use of psychotropic medication for punishment, convenience of the staff, or as a substitute for adequate programming for
foster care youth.143 Illinois law also prohibits as needed (or “PRN”)
medications for treatment of psychiatric illnesses and behavioral
problems.144
To address the federal requirement for oversight, the Illinois law has
a list of nine “triggers” that could lead to case review by an oversight
team.145 Some triggers include: prescription of four or more psychotropic
medications; prescription of psychotropic medication to a foster care
child under the age of four; frequent changes in psychotropic medications without clear rational; and the request of the Division of Child and
Family Services (DCFS) guardian.146
The Illinois statute also includes guidelines for group homes, temporary placements, and foster homes.147 It contains specific standards for
consent as well as penalties for violations of the statute.148 The specificity and clarity in this statute prevents different standards regarding medication between group and foster home placements. As with the Nevada
140

NEV. REV. STAT. § 432B.4687 (West 2015).
Id. § 432B.4687(1)(a).
142
20 ILL. COMP. STAT. 535/5(f) (West 2015).
143
Id. 535/5(e).
144
ILL. ADMIN. CODE tit. 89, § 325.30 (West 2012).
145
Id.
146
Id.
147
Id.
148
Id.
141
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and Texas statutes, explicit instructions regarding consent mitigate the
chances that a youth will be required to take psychotropic medication
against their will or the will of their family/caretakers. It reduces ambiguity about who is responsible for the psychiatric care of a foster care
youth.
In Illinois’ guidelines, legislation also calls for collaboration between medical providers. This communication enhances the “continuity
of care” and “facilitate[s] the monitoring of the outcome of the medication trial.”149
B. HOW CALIFORNIA MEASURES UP
Compared to the robust oversight and monitoring provisions of the
model state laws described above, California’s current law contains serious deficiencies that leave youth in the foster system at risk of over- or
inappropriate medication. As described above, California code requires
approval by a judicial officer prior to the administration of psychotropic
medication, but the information that an officer receives is inadequate to
ensure that the youth’s interest is fully protected.
When a youth enters the foster care system, by California law, the
juvenile court takes jurisdiction and is granted parens patriae power over
the child.150 This power is derived from the fact that the youth’s parents
are unfit, unwilling, or unable to care for them.151 Parens patriae power
can be exercised “only to further the best interests of the child.”152
As part of this parens patriae power, only a judicial officer is required to sign off on psychotropic medications for foster care youth.153
The judicial officer is not required to have any training in consent,
psychotropic medications, or mental health treatment.154 The only information about the medication that the prescribing physician is required to
attach to the JV-220 is its name, dosage, the condition that it will be
treating, and its potential side effects.155 Far from providing comprehensive data, the prescribing physicians generally attach generic printouts
about the medication that do not address the risks pertaining to the specific child.
149

Id.
Maggie Brandow, A Spoonful of Sugar Won’t Help This Medicine Go Down: Psychotropic
Drugs for Abused and Neglected Children, 72 S. CAL. L. REV. 1151, 1160 (1999).
151
Id.
152
Id.
153
CAL. WELF. & INST. CODE § 369.5(a) (West 2015).
154
CAL. R. CT. 5.640.
155
CAL. R. CT. 5.640(c)(6)(A) (G); JUDICIAL COUNCIL OF CALIFORNIA, APPLICATION REGARDING PSYCHOTROPIC MEDICATION (2008), http://www.courts.ca.gov/documents/jv220.pdf.
150
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Additionally, the judicial officer does not necessarily have a relationship with the child or their caregivers.156 After the dependency court
obtains jurisdiction over a child, a review hearing is only required on a
biannual basis.157 The social worker submits a report to the judge that
includes information on the youth’s mental health and current medication, but the judicial officer has no obligation to personally interact with
the youth or their support network.158 Outside of a JV-222 Opposition
form or communication with the social worker, there is no meaningful
way for adults in the foster care youth’s life to provide input regarding
the youth’s behavior and treatment responses.
The approval of psychiatric medication ends up being a “rubberstamp” of the physician’s request due to the judicial officer’s lack of
information. The judicial officer is therefore poorly positioned to make
any decision regarding psychotropic medication except as a last resort.
While SB 253 would have addressed many of these shortcomings, it did
not pass and consequently California’s foster youth are left without this
protection.
III. RECOMMENDATION
For an amendment to California’s Welfare & Institutions Code to
effectively provide oversight and monitoring of psychotropic medication
prescriptions to youth in foster care, it must require more than simple
approval by a judicial officer under a standard of preponderance of the
evidence. Additional oversight not only protects foster youth, but increases the state’s accountability and establishes consistent standards
among the counties. As demonstrated by the laws in Texas, Nevada, and
Illinois, an effective state policy requires informed consent, red flag
“triggers” for case review, and monitoring of foster youth on psychotropic medications.
Further, the standard of review is critical since the court is reviewing
the request for medication. For adults in the prison or civil commitment
system to be prescribed involuntary medication, the court must make
findings that it is necessary by a standard of clear and convincing evidence. At the very least, foster youth should have this higher standard to
protect them from overmedication and further abuses.

156
See generally Brandow, A Spoonful of Sugar Won’t Help This Medicine Go Down:
Psychotropic Drugs for Abused and Neglected Children, 72 S. CAL. L. REV. at 1162.
157
CAL. WELF. & INST. CODE § 366(a)(1).
158
See generally Brandow, supra note 155.
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A. RATIONALE FOR RECOMMENDED REVISIONS TO STATE LAW
There are four main reasons why a state law is appropriate to address the crisis of overmedication: uniformity among counties; the power
of a state law; the ongoing risk to foster youth; and the role of the court
as the foster youth’s parent. First, for youth in foster care who may experience repeated changes prior to and while in foster care, uniformity is
crucial. Foster children often have frequent placement changes,159 and
due to variances in county guidelines, their treatment can be interrupted
upon moving. A state law allows foster children to move if necessary
without this interruption. The children in each county should be entitled
to the same standard of care regarding their medical health. For DeAngelo, while some of the placement changes may have been unavoidable, a more comprehensive state law would have mandated that he
receive continuing medical care throughout his time in foster care. Consistency in his medication may have enabled his doctors to determine
which medications were helping him, or if the medications were helping
at all.
In addition to uniformity, a state law has greater force than a policy
or guideline. The state has an obligation to ensure that all children within
its care are protected. It is responsible for the care of these neglected and
abused children as they are a vulnerable population, and there are serious
risks to the mismanagement of psychotropic medications. Counties can
presently create different policies if justified but many foster youth move
between counties, resulting in a change or deprivation of services. Further, neighboring counties are not required to uphold bordering counties’
standards. A state law sets a base of protection that is unchanging.
As detailed above, without the needed oversight, California’s large
foster care population is currently being prescribed psychotropic medication at a much higher rate than children not in foster care.160 There are no
guidelines for how much mental treatment youth should receive in addition to psychotropic medication, and the prescribing physician is under
no legal obligation to follow up with the child after they begin taking
their medication. The procedure for consent is not outlined explicitly, nor
is there required training for the individual responsible for consenting. In
the short-term, children are suffering from side effects and being treated
as nuisances in need of control instead of as traumatized individuals in
need of treatment. In the long-term, foster youth are more likely to end
159

Donald H. Stone, The Dangers of Psychotropic Medication for Mentally Ill Children:
Where is the Child’s Voice in Consenting to Medication? An Empirical Study, 23 TEMP. POL. & CIV.
RTS. L. REV 121, 144 (2013).
160
Id.
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up homeless, incarcerated, or suffering from chronic health problems due
to a failure to treat their underlying mental health needs.161
Finally, the state, in its parens patriae role, should be held responsible for the children in its care. This duty extends not only to the foster
youth, but also to society as a whole, which ultimately pays the cost of
caring for foster children. A parent who negligently or recklessly managed a child’s medication over a long period of time may be subject to
intervention by child welfare services or even criminal charges. The
state, unlike a parent, cannot maintain close contact with each minor in
its care,162 but nevertheless has an obligation to ensure that the child’s
mental health needs are met. A law detailing this obligation supports the
state in its role by specifying the inquiries that it should make prior to
approving an order for psychotropic medication.
B. PROPOSED LAW
To satisfy the federal government’s requirement for oversight and
monitoring, and to consider the child’s best interest, an amendment to
California’s law should include strong provisions with strict requirements for three areas: consent, red flags for case review, and requirements for follow up and monitoring.
1. Consent
For consent, Texas’s law stands as a guide. If a child is removed
from his or her home, a court-appointed adult must consent in writing to
any prescription for any psychotropic medication.163 The court may appoint the child’s foster parent, the social worker, or the agency as a
whole as the responsible adult.164 When foster care youth enter the foster
care system, they may or may not have immediate psychiatric needs. If
they do, California’s law should require the immediate identification of
an adult who will be responsible for consenting to their psychiatric care.
The individual empowered to consent should receive training on informed consent and the medication application procedure.165 This man161
Youth Homelessness in California: A Quick Overview, CALIFORNIA HOMELESS YOUTH
PROJECT, http://cahomelessyouth.library.ca.gov/docs/pdf/a-quickoverview-of-hy-inca.pdf (last visited April 17, 2016).
162

Brandow, A Spoonful of Sugar Won’t Help This Medicine Go Down: Psychotropic Drugs
for Abused and Neglected Children, 72 S. CAL. L. REV. at 1162.
163
TEX. FAM. CODE ANN. § 266.004(b) (West 2015).
164
Id. § 266.004(b)(1) (2).
165
Id. § 266.04(h), (h-1), (h-2).
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ner of appointment is similar to how an educational rights holder is
currently appointed in California.
California should adopt this procedure for consent because it places
power to consent for medication onto an individual who interacts with
the child rather than the court. In California, a minor twelve or older can
refuse treatment by means of psychotropic medication.166 However, refusal serves more as a last-ditch protection for the youth than as a procedural safeguard that is required for every prescription. To facilitate
informed consent, the AACAP encourages both the child and the
caregiver to be “meaningful participants” in the conversation with the
prescriber to facilitate the consent process.167 In DeAngelo’s case, had
there been an adult responsible for consenting to his psychotropic medications, this adult would have been able to provide up-to-date medical
information to the prescribing doctors to inform their diagnoses. After
consultation with DeAngelo, they might have made different decisions
about psychotropic medications. The adult could have informed the doctor about Deangelo’s trauma or placement history, which likely impacted
his behavior. The adult could have affirmatively advocated for a nonpharmaceutical treatment to address specific challenges.
2. Case Review
For red flags, California should, at a minimum, have automatic case
review in the following circumstances: when any psychotropic medication is prescribed to a foster child under a certain age; when a child is
prescribed two or more psychotropic medications for the same condition;
when there are frequent changes to a child’s psychotropic medication;
when there is an emergency situation involving psychotropic medication;
and at the request of the foster home caretaker. In addition to these, California may consider discretionary case review for: certain dosage levels;
medications with a black box label (suicide risk as a side effect); and
other factors such as the child’s age, diagnosis, or placement changes.
Most of these triggers are included in Illinois state law. SB 253 would
have included several of these provisions.168
Further, California should require that information about all of the
psychotropic medication be placed in a public forum, such as on the
166

Brandow, supra note 160, at 1154.
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at 149.
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Juveniles: Psychotropic Medication, S.B. 253, 2015-16 Sess. (Cal. 2015), http://
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state’s website.169 Upon submission of JV-220, the parent should be directed to this information. Publication of psychotropic medication data,
side effects, and warnings promote transparency and education. Those
individuals who may not have received the JV-220 request can still look
up the state’s guidelines regarding psychotropic medications. Additionally, an individual who is included in the JV-220’s notice requirement
can have access to more information about the medication or policy than
may have been provided in the three-page court document.
With case review, the county or state should establish a team to conduct the review. In other states, this team has multi-disciplinary professionals from several facets of childcare and child psychiatry.170 A team
like this should meet regularly or be on call to review the children’s
cases or to meet with the children if necessary. Their assessment should
be conducted independently of the child welfare agency, though they
may collaborate in coming to a solution if changes are required. This
independent assessment allows for objectivity in a setting where emotions may affect the judgment or requests of the support team involved in
the foster child’s care. Further, review by a neutral third-party prevents
instances of overmedication urged by caregivers as a means of sedating a
youth in their care.
Both DeAngelo and Gabriel’s cases would have required—and
likely benefitted from—case review. For Gabriel, case review would
have been required due to his age. For DeAngelo, case review would
have been required due to the combination of medications he was receiving. This additional attention to youth with troublesome mental health
conditions provides another access point for professional assessment,
collaboration, and intervention.
3. Monitoring
All children who are prescribed psychotropic medication should also
have more frequent and in-depth monitoring due to the risks inherent in
the medication. Upon entry into the dependency system, each youth
should have a medical screening that includes evaluation of the child’s
psychiatric needs.171 If the child requires or is already taking psychotropic medication upon entry into the child welfare system, the court
169

See 20 ILL. COMP. STAT. ANN. 535/5(f) (West 2011).
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should determine who is responsible for the child’s psychiatric care at
the detention hearing.
Once the child is prescribed medication, there should be a requirement for ongoing treatment.172 California should adopt Texas’s policy,
which requires that a child in the dependency system who is on psychotropic medication should see their prescribing psychiatrist at least every
ninety days.173 Maintaining contact with a psychiatrist is one piece of
treatment that is vital to recovery from mental health conditions. In a
growing body of smaller studies, treatment that includes a stable home
environment, caring adults, and focus on the full effect of maltreatment
has shown to be an effective alternative to psychotropic treatment.174 To
encourage the integration of such treatment, at each hearing, the psychiatrist or child welfare agency should be required to inform the court of
non-pharmacological options to treatment.175
For effective monitoring, collaboration between the youth’s providers is essential. As found in the guidelines in Illinois, California law
should require psychiatrists that prescribe for dependent youth to communicate with the youth’s other providers and document these contacts.176 Correspondence between the child’s providers decreases the
likelihood that multiple medications are prescribed unintentionally. For a
youth like Gabriel, correspondence and collaboration between his prescribing physicians, parents, and caregivers would likely have resulted in
a comprehensive treatment plan that spanned each facet of his life. Instead, his treatment was fragmented and each adult in Gabriel’s life dealt
with his problem behavior in a different way.
Children in the child welfare system often have mental health needs
due to the trauma they experienced that led to state intervention.177 However, they generally aren’t getting “consistent, appropriate mental health
care of any kind.”178 There is no decisive test to determine whether
mental illness is the cause of a youth’s behavior problems,179 so nonpharmacological treatment is vital to a child’s success with or without
prescription medication.
172
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All provisions of the proposed law mean little if the state only need
show that the child “more likely than not” meets each of these criteria.
The risk of severe side-effects alone warrants a clear finding of need in
order for the new amendment to offer any viable protection for foster
youth.
C. STANDARD OF REVIEW
While the interest in the child’s well-being is specified by state law,
there is no consistent interested party to provide informed consent or ask
the questions a typical parent asks. Therefore, the court should be held to
a higher standard of evidence to ensure that the child is not being medicated unnecessarily. The AACAP guidelines underscore this need,
Unlike mentally ill children from intact families, these children often
have no consistent interested party to provide informed consent for their
treatment, to coordinate treatment planning and clinical care, or to provide longitudinal oversight of their treatment. The state has a duty to
perform this protective role for children in state custody.180
Further, as medication is a bodily intrusion that, if unwarranted, is a
gross violation of the youth’s right to privacy, a finding of clear and
convincing evidence is fitting for the State’s parens patriae responsibility to the youth.
In an early challenge to involuntary mental health treatment for
adults, the First District Court of Appeal determined that clear and convincing evidence was required to support an order that a patient lacked
capacity to consent to convulsive treatment.181 Because of the “intrusive”
and “possibly hazardous” nature of convulsive therapy, the court noted
additional safeguards had justifiably been put in place for treatment of
involuntarily committed patients.182 The court balanced the concerns of
the state and the patient to determine which standard of proof should be
required for these invasive treatments.183
The court underscored the way convulsive treatment impacts “the
right to be free in the exercise of one’s own thoughts. . . .”184 Because of
the effect on this personal and integral right, the practice of involuntarily
treating someone can only be sustained through a showing that there is a
180
AM. ACAD. OF CHILD & ADOLESCENT PSYCHIATRY, A GUIDE FOR COMMUNITY CHILD
SERVING AGENCIES ON PSYCHOTROPIC MEDICATIONS FOR CHILDREN AND ADOLESCENTS, 18 (2012),
http://www.aacap.org/app_themes/aacap/docs/press/guide_for_community_child_serving_agencies_on_psychotropic_medications_for_children_and_adolescents_2012.pdf.
181
Lillian F. v. Super. Ct., 160 Cal. App. 3d 314, 324 (Ct. App. 1984).
182
Id. at 317.
183
Id. at 321.
184
Id. at 321 (citing Aden v. Younger, 57 Cal. App. 3d 662, 67980 (1976)).
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compelling state interest and that the least drastic means have been used
to employ those interests.185 Accordingly, the court determined that “preponderance of the evidence” was inappropriate because society’s interest
in preventing erroneous determination of the power to consent was
greater than interest in an erroneous money award in a civil suit.186 Further, as the proceeding in that case was not a criminal one, the “clear and
convincing” standard was appropriate.187 “The clear and convincing evidence test is consistent with the balancing of these interests and the
proper allocation of the risk of error.”188
Children are at least entitled to the liberty interest protections of
prisoners. Society’s interest in whether children are receiving the appropriate standard of care prior to being medicated with serious psychotropic medication is more substantial than its interest in resolution of a
civil suit for monetary damages. A preponderance of the evidence standard does not safeguard the rights of foster youth, who may be left without a single, consistent advocate to ask the questions required to ensure
they receive adequate protection from overmedication.
Even though it satisfies the preponderance of the evidence standard,
a reasonable parent asks more than whether the medication is more likely
than not to produce the desired effect. A reasonable parent asks: what
other treatment options have we tried? Is this the only way? Will my
child suffer from the side effects? Does my child want to take this medication? In applying a clear and convincing standard, the court is more
likely to ask questions that are within its duty as the child’s parent.
This amendment permits medication as a part of a comprehensive
treatment plan, not as a first resort for behavior control. A law that includes consent, red flags, and monitoring, evaluated at a standard of review of clear and convincing evidence comes as close as California can
to providing foster youth with the benefit of a parent’s oversight and
monitoring.
CONCLUSION
California’s current regulatory regime has weaknesses that affect the
state’s most vulnerable children, and it needs to be brought into step with
the best practices that are working effectively today to protect children in
other states. Presently, the law only calls for court approval by a standard
of preponderance of the evidence. This falls dangerously short of the
185
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holistic, comprehensive, collaborative approach that other states have implemented and that is recommended by the AACAP. For children like
DeAngelo and Gabriel, the lack of oversight of prescribed psychotropic
medications led to unnecessary harm. The state removed them from their
homes to prevent abuse and neglect, but only furthered their trauma
through well-intentioned pharmacological intervention. Further, the state
neglected their mental health needs by failing to implement a collaborative treatment plan.
To protect children that come into the foster care system with psychiatric needs, California needs to have a comprehensive, youth-centered
approach to mental health treatment. At a minimum, California legislation should include oversight, as required by the federal law that addresses consent, case review, and monitoring for youth in foster care at a
standard of clear and convincing evidence. While key stakeholders continue to take strides to address legislative gaps in services,189 foster youth
remain vulnerable to overtreatment in the meantime. The state takes responsibility for foster youth as soon as it deems the child’s parents incapable of doing so, and this should include concern for children’s
psychiatric needs. With legislative oversight, California can end the crisis of overmedication that currently exists in our foster care system.

189

As of this Comment’s publication, Senate Bill 1174 is making its way through the legislative hearing process. SB 1174 would provide greater authority for the California Medical Board to
penalize doctors who regularly overprescribe psychotropic medication to minors without medical
justification. See Karen de Sá, Drugging Our Kids: Foster care bill targets excessive prescribing of
psychiatric drugs, DAILY DEMOCRAT (April 11, 2016, 7:28PM), http://www.dailydemocrat.com/general-news/20160411/drugging-our-kids-foster-care-bill-targets-excessive-prescribing-of-psychiatricdrugs. Additionally, implementation of Senate Bill 238 (mentioned infra page 17) begins July 2016.
Under new guidelines, doctors will be required to state their rationale for prescription medication,
indicate whether the child agrees with the treatment, conduct all appropriate labs and explain how
the medication is expected to improve the child’s symptoms. The changes do not require case review
or ongoing monitoring of the child’s treatment. See Karen de Sá, California courts step up oversight
of psychotropic medication use in foster care, SAN JOSE MERCURY NEWS (April 15, 2016, 4:59PM),
http://www.mercurynews.com/breaking-news/ci_29772962/california-courts-step-up-oversightpsychotropic-medication-use; see infra p. 17 and note 125.
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